Modified Shenlingbaizhu decoction reduces intestinal adenoma formation in adenomatous polyposis coli multiple intestinal neoplasia mice by suppression of hypoxia-inducible factor 1a-induced CD4+ CD25+forkhead box P3 regulatory T cells

OBJECTIVE: To test the hypothesis that modified Shenlingbaizhu decoction (MSD) attenuates the for- mation of intestinal adenomas by regulating activa- tion of CD4+CD25+ forkhead box P3 (FoxP3) regu- latory T cells (Tregs) by downregulation of hypox- ia-inducible factor la (HIF-la). METHODS: Chemical...

Full description

Saved in:
Bibliographic Details
Published in中医杂志:英文版 Vol. 38; no. 1; pp. 22 - 32
Main Author Xu Wenjuan;Han Qinrui;Liang Shuntian;Li Lu;Shao Meng;Yao Xueqing;Sun Xuegang
Format Journal Article
LanguageEnglish
Published 2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:OBJECTIVE: To test the hypothesis that modified Shenlingbaizhu decoction (MSD) attenuates the for- mation of intestinal adenomas by regulating activa- tion of CD4+CD25+ forkhead box P3 (FoxP3) regu- latory T cells (Tregs) by downregulation of hypox- ia-inducible factor la (HIF-la). METHODS: Chemical fingerprints of ginsenoside Rbl, ginsenoside Rc, paeoniflorin, and dioscin in standard extractions were used as material bases of MSD. Adenomatous polyposis coli multiple intesti- nal neoplasia (ApcM'n/+) mice, which harbor a muta- tion in adenomatous polyposis coil, were used to host intestinal adenomas. Peripheral blood and spleen Tregs were analyzed by flow cytometry. Pro- tein expression was analyzed by immunohisto- chemistry and Western blotting. RESULTS: The number and size of intestinal adenomas were significantly reduced by MSD treatment. Mucosal thickening and the spleen size were also substantially decreased by MSD. The carcinogenesis process in Apc^min/+ mice resembled that of human colorectal cancer. Molecular markers of neoplasms, such as 13-catenin, cyclooxygenase-2, prolif- erating cell nuclear antigen, and p53, were substantially ameliorated by MSD treatment. Moreover, MSD downregulated peripheral and spleen CD4+ CD25+FoxP3+ Tregs and reduced in situ expression of CD4, CD25, and FoxP3 in intestinal adenomas. MSD also suppressed HIF-la expression in the intestinal adenomas, and HIF-la inhibition decreased expression of FoxP3 in Jurkat T cells under hypoxic conditions. CONCLUSION: MSD is a valid prescription to control the formation of intestinal adenomas in Apc^min/+mice. It exerts anti-cancer effects partially through suppression of HIF-la that induced activation of CD4+CD25+FoxP3+ Tregs in vivo and in vitro.
Bibliography:OBJECTIVE: To test the hypothesis that modified Shenlingbaizhu decoction (MSD) attenuates the for- mation of intestinal adenomas by regulating activa- tion of CD4+CD25+ forkhead box P3 (FoxP3) regu- latory T cells (Tregs) by downregulation of hypox- ia-inducible factor la (HIF-la). METHODS: Chemical fingerprints of ginsenoside Rbl, ginsenoside Rc, paeoniflorin, and dioscin in standard extractions were used as material bases of MSD. Adenomatous polyposis coli multiple intesti- nal neoplasia (ApcM'n/+) mice, which harbor a muta- tion in adenomatous polyposis coil, were used to host intestinal adenomas. Peripheral blood and spleen Tregs were analyzed by flow cytometry. Pro- tein expression was analyzed by immunohisto- chemistry and Western blotting. RESULTS: The number and size of intestinal adenomas were significantly reduced by MSD treatment. Mucosal thickening and the spleen size were also substantially decreased by MSD. The carcinogenesis process in Apc^min/+ mice resembled that of human colorectal cancer. Molecular markers of neoplasms, such as 13-catenin, cyclooxygenase-2, prolif- erating cell nuclear antigen, and p53, were substantially ameliorated by MSD treatment. Moreover, MSD downregulated peripheral and spleen CD4+ CD25+FoxP3+ Tregs and reduced in situ expression of CD4, CD25, and FoxP3 in intestinal adenomas. MSD also suppressed HIF-la expression in the intestinal adenomas, and HIF-la inhibition decreased expression of FoxP3 in Jurkat T cells under hypoxic conditions. CONCLUSION: MSD is a valid prescription to control the formation of intestinal adenomas in Apc^min/+mice. It exerts anti-cancer effects partially through suppression of HIF-la that induced activation of CD4+CD25+FoxP3+ Tregs in vivo and in vitro.
11-2167/R
Colorectal neoplasms; T-lymphocytes, regulatory; Hypoxia-inducible factor 1, alpha sub- unit; Forkhead transcription factors; Modified Shenlingbaizhu decoction
ISSN:0255-2922